Bridgeway Capital Management, LLC Galera Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.5 - $3.42 $62,500 - $85,500	25,000 Added 28.74%	112,000 $349,000
Q1 2023 May 15, 2023	SELL	$1.48 - $2.68 $148,000 - $268,000	-100,000 Reduced 53.48%	87,000 $222,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.39 $49,600 - $95,600	40,000 Added 27.21%	187,000 $243,000
Q1 2022 May 16, 2022	BUY	$2.01 - $4.19 $200,999 - $419,000	100,000 Added 212.77%	147,000 $350,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $8.28 $84,836 - $553,104	-66,800 Reduced 58.7%	47,000 $216,000
Q3 2021 Nov 15, 2021	BUY	$7.04 - $10.49 $26,752 - $39,862	3,800 Added 3.45%	113,800 $922,000
Q2 2021 Aug 16, 2021	BUY	$6.08 - $10.44 $121,600 - $208,800	20,000 Added 22.22%	110,000 $1.08 Million
Q1 2021 May 17, 2021	BUY	$8.35 - $12.39 $751,500 - $1.12 Million	90,000 New	90,000 $794,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.